載入...
Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma
The clinical management of relapsed/refractory multiple myeloma and the correct choice of the most suitable therapy in heavily pretreated and fragile patients are tough clinical issues for clinicians. In advanced phases of disease, the choice of available therapies becomes very poor, and the retreat...
Na minha lista:
| 發表在: | Case Rep Hematol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Publishing Corporation
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5102715/ https://ncbi.nlm.nih.gov/pubmed/27867671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6745286 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|